FdaApplication
ANDA 213654
Identifiers
- fda_app_no: ANDA213654
Properties
| Property | Value |
|---|---|
| applicant_name | LUPIN LTD |
| application_type | ANDA |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 5MG;1GM | TABLET, EXTENDED RELEASE;ORAL |
| EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 12.5MG;1GM | TABLET, EXTENDED RELEASE;ORAL |
| EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 10MG;1GM | TABLET, EXTENDED RELEASE;ORAL |
| EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 25MG;1GM | TABLET, EXTENDED RELEASE;ORAL |
4 products